Cargando…

Neuroinflammation and amyloid deposition in the progression of mixed Alzheimer and vascular dementia

BACKGROUND: Alzheimer’s disease (AD) and vascular contributions to cognitive impairment and dementia (VCID) pathologies coexist in patients with cognitive impairment. Abnormal amyloid beta (Aβ) deposition is the hallmark pathologic biomarker for AD. Neuroinflammation may be a pathophysiological mech...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ying, Chunwei, Kang, Peter, Binkley, Michael M., Ford, Andria L., Chen, Yasheng, Hassenstab, Jason, Wang, Qing, Strain, Jeremy, Morris, John C., Lee, Jin-Moo, Benzinger, Tammie L.S., An, Hongyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036862/ https://www.ncbi.nlm.nih.gov/pubmed/36933348 http://dx.doi.org/10.1016/j.nicl.2023.103373

Ejemplares similares

The effects of white matter hyperintensities and amyloid deposition on Alzheimer dementia
por: Gordon, Brian A., et al.
Publicado: (2015)

Lack of association between acute stroke, post-stroke dementia, race, and β-amyloid status
por: Koenig, Lauren N., et al.
Publicado: (2021)

Select Atrophied Regions in Alzheimer disease (SARA): An improved volumetric model for identifying Alzheimer disease dementia
por: Koenig, Lauren N., et al.
Publicado: (2020)

Automated quantification of cerebral edema following hemispheric infarction: Application of a machine-learning algorithm to evaluate CSF shifts on serial head CTs
por: Chen, Yasheng, et al.
Publicado: (2016)

Association of sex and APOE ε4 with brain tau deposition and atrophy in older adults with Alzheimer's disease
por: Yan, Shaozhen, et al.
Publicado: (2020)

Quantification of white matter cellularity and damage in preclinical and early symptomatic Alzheimer's disease
por: Wang, Qing, et al.
Publicado: (2019)

Two-period linear mixed effects models to analyze clinical trials with run-in data when the primary outcome is continuous: Applications to Alzheimer's disease
por: Wang, Guoqiao, et al.
Publicado: (2019)

Neuroinflammation and Myelin Status in Alzheimer's Disease, Parkinson's Disease, and Normal Aging Brains: A Small Sample Study
por: Han, Fei, et al.
Publicado: (2019)

Utilizing the Centiloid scale in cross-sectional and longitudinal PiB PET studies
por: Su, Yi, et al.
Publicado: (2018)

Is comprehensiveness critical? Comparing short and long format cognitive assessments in preclinical Alzheimer disease
por: Hassenstab, Jason, et al.
Publicado: (2021)

Simultaneously evaluating the effect of baseline levels and longitudinal changes in disease biomarkers on cognition in dominantly inherited Alzheimer's disease
por: Wang, Guoqiao, et al.
Publicado: (2018)

The effect of ApoE ε4 on longitudinal brain region-specific glucose metabolism in patients with mild cognitive impairment: a FDG-PET study
por: Paranjpe, Manish D., et al.
Publicado: (2019)

Clinical and MRI models predicting amyloid deposition in progressive aphasia and apraxia of speech
por: Whitwell, Jennifer L., et al.
Publicado: (2016)

The relationships between neuroinflammation, beta-amyloid and tau deposition in Alzheimer’s disease: a longitudinal PET study
por: Ismail, Rola, et al.
Publicado: (2020)

Increasing hub disruption parallels dementia severity in autosomal dominant Alzheimer disease
por: Tu, Jiaxin Cindy, et al.
Publicado: (2023)

Translocator protein in late stage Alzheimer’s disease and Dementia with Lewy bodies brains
por: Xu, Jinbin, et al.
Publicado: (2019)

Cerebral Oxygen Metabolic Stress, Microstructural Injury, and Infarction in Adults With Sickle Cell Disease
por: Wang, Yan, et al.
Publicado: (2021)

Misery perfusion and amyloid deposition in atherosclerotic major cerebral artery disease
por: Yamauchi, Hiroshi, et al.
Publicado: (2019)

Sex-Specific Patterns of Body Mass Index Relationship with White Matter Connectivity
por: Rahmani, Farzaneh, et al.
Publicado: (2022)

Investigating the Spatial Associations Between Amyloid-β Deposition, Grey Matter Volume, and Neuroinflammation in Alzheimer’s Disease
por: Jorge, Lília, et al.
Publicado: (2021)

Amyloid deposition in semantic dementia: a positron emission tomography study
por: Brown, Eric E., et al.
Publicado: (2016)

Lesion evolution and neurodegeneration in RVCL-S: A monogenic microvasculopathy
por: Ford, Andria L., et al.
Publicado: (2020)

Sex modulates the ApoE ε4 effect on brain tau deposition measured by (18)F-AV-1451 PET in individuals with mild cognitive impairment
por: Liu, Min, et al.
Publicado: (2019)

Deep residual inception encoder‐decoder network for amyloid PET harmonization
por: Shah, Jay, et al.
Publicado: (2022)

Diurnal Patterns of Soluble Amyloid Precursor Protein Metabolites in the Human Central Nervous System
por: Dobrowolska, Justyna A., et al.
Publicado: (2014)

Brain-predicted age in Down syndrome is associated with beta amyloid deposition and cognitive decline
por: Cole, James H., et al.
Publicado: (2017)

Quantitative Amyloid Imaging Using Image-Derived Arterial Input Function
por: Su, Yi, et al.
Publicado: (2015)

What Are the Molecular Mechanisms by Which Functional Bacterial Amyloids Influence Amyloid Beta Deposition and Neuroinflammation in Neurodegenerative Disorders?
por: Friedland, Robert P., et al.
Publicado: (2020)

Cross-sectional and longitudinal atrophy is preferentially associated with tau rather than amyloid β positron emission tomography pathology
por: Gordon, Brian A., et al.
Publicado: (2018)

Molecular imaging of the association between serotonin degeneration and beta-amyloid deposition in mild cognitive impairment
por: Smith, Gwenn S., et al.
Publicado: (2023)

PET evidence of preclinical cerebellar amyloid plaque deposition in autosomal dominant Alzheimer’s disease-causing Presenilin-1 E280A mutation carriers
por: Ghisays, Valentina, et al.
Publicado: (2021)

Early Life Obesity Increases Neuroinflammation, Amyloid Beta Deposition, and Cognitive Decline in a Mouse Model of Alzheimer’s Disease
por: So, Simon W., et al.
Publicado: (2023)

The combined effect of amyloid-β and tau biomarkers on brain atrophy in dementia with Lewy bodies
por: Abdelnour, Carla, et al.
Publicado: (2020)

Clinical and imaging correlates of amyloid deposition in dementia with Lewy bodies
por: Donaghy, Paul C., et al.
Publicado: (2018)

Brain aerobic glycolysis and resilience in Alzheimer disease
por: Goyal, Manu S., et al.
Publicado: (2023)

Differentiating amyloid beta spread in autosomal dominant and sporadic Alzheimer’s disease
por: Levitis, Elizabeth, et al.
Publicado: (2022)

An individual with human immunodeficiency virus, dementia, and central nervous system amyloid deposition
por: Turner, Raymond Scott, et al.
Publicado: (2016)

Agomelatine Prevents Amyloid Plaque Deposition, Tau Phosphorylation, and Neuroinflammation in APP/PS1 Mice
por: Yang, Xiao-bo, et al.
Publicado: (2022)

Dopamine D1 + D3 receptor density may correlate with parkinson disease clinical features
por: Yang, Pengfei, et al.
Publicado: (2020)

Serum metabolites associated with brain amyloid beta deposition, cognition and dementia progression
por: Nho, Kwangsik, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a5or1ii77paeb8imq5e98qssot